Today: 11 June 2026
McDonald’s stock nears a 52-week high heading into earnings week: what to watch next
7 February 2026
1 min read

McDonald’s stock nears a 52-week high heading into earnings week: what to watch next

New York, Feb 7, 2026, 16:23 EST — The session’s over.

McDonald’s Corp (MCD) climbed 1.1% to close at $327.16 on Friday, just shy of its 52-week high. Investors are looking ahead to earnings and a packed U.S. data slate next week. Volume lagged the recent average.

This setup is key: McDonald’s shares have climbed close to their previous highs, but that rally’s come without a new earnings report. That leaves little margin for error in the company’s guidance or remarks. For the fourth quarter, analysts surveyed by Zacks — via Yahoo Finance — are calling for earnings of $3.04 per share.

Valuation concerns crept in as analyst notes grew slightly more cautious. Mizuho bumped its price target on McDonald’s up to $325 from $300 on Friday, sticking with a “neutral” rating. A price target reflects a broker’s view of where the stock might land in the next year. MarketBeat

Friday saw a lift across the board. The Dow finished above 50,000 for the first time ever, with the S&P 500 and Nasdaq both logging strong gains—plenty of big caps went along for the ride into the weekend.

Investors are bracing for the U.S. January consumer price index, set for release Feb. 13 at 8:30 a.m. ET. The inflation data has the potential to shake up rate expectations—moves that tend to spill into defensive staples and restaurant stocks.

McDonald’s tends to get measured on a tighter set of numbers: comparable sales, or same-store sales—meaning locations running for at least a year—as well as traffic and how pricing shakes out. Investors are watching for signals on whether value deals are resonating with budget-conscious diners, and if international demand is finding its footing.

But there’s a risk: if executives hint at softer traffic, more aggressive discounts, or squeezed margins—maybe from food, labor, or promos—a stock trading close to its peak can tumble fast, even when headline earnings don’t miss by much.

McDonald’s is pressing up against its recent highs. Shares have traded between $283.47 and $328.06 over the past year, and Friday’s finish sits near that upper bound. Momentum-focused investors could insist on a strong showing to justify holding on.

Plenty on deck for fast-food names this week, which tends to stir sentiment regardless of the news flow. Eyes will be on Restaurant Brands International, slated to drop its fourth-quarter numbers Feb. 12.

McDonald’s faces its next big test with earnings set for Feb. 11. Investors will be paying close attention to what executives say about guidance and any hints they offer on demand heading into 2026. Just two days later, on Feb. 13, comes the CPI print.

Stock Market Today

  • Wall Street Gains on AI Stock Rally Amid Inflation and Middle East Tensions
    June 11, 2026, 11:16 AM EDT. Wall Street recovered some weekly losses Thursday as artificial intelligence (AI) stocks rebounded, led by chipmakers like Marvell Technology (+5.5%), Intel (+7.8%), and Applied Materials (+7.5%). The S&P 500 rose 0.5%, Dow Jones 0.7%, and Nasdaq 0.7%. Despite market gains, concerns about elevated AI valuations persist, while Oracle shares fell 11.1% after revealing plans to raise $40 billion to fund AI investments. Oil prices remained steady despite rising tensions in the Iran conflict, with Brent crude at $92.64 and U.S. crude at $90.29 per barrel. Meanwhile, wholesale inflation in the U.S. exceeded expectations in May, prompting the European Central Bank to raise interest rates, signaling global inflationary pressures.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Gold price near $5,000: China keeps buying as CME margin hikes raise the stakes
Previous Story

Gold price near $5,000: China keeps buying as CME margin hikes raise the stakes

Deutsche Telekom stock slips despite fresh buyback — what matters before earnings
Next Story

Deutsche Telekom stock slips despite fresh buyback — what matters before earnings

Go toTop